Pharma 6: Antidepressant And Antipsychotic Drugs Flashcards
Selective Serotonin Reuptake Inhibitors
Fluoxetine Citalopram
Fluoxetine Citalopram Selectivity to serotonin transporter
300-3000 greater for serotonin than noradrenaline
Fluoxetine, citalopram Adverse effects
Safer than TCAs and MAOI so they’ve replaced them
Fluoxetine, citalopram Therapeutic uses
-Very effective in treating “moderate” depression - Less effective than TCAs in treating severe depression -Treats bulimia nervosa, OCD, anorexia nervosa, panic disorder.
Pharmacokinetics of Fluoxetine, Citalopram
- Absorbed orally - Fluoxetin—>potent inhibitor of CYP2D6 (metabolized TCAs, antipsychotics, antiarrythmatics, B antagonists) - If pt has hepatic impairment—> reduce dose of SSRI
Fluoxetine, Citalopram Adverse effect
-nausea -anxiety -insomnia -anorexia -weight loss -tremors -sexual dysfunction
Antidepressants and <18 years
CAUTION! Possibly causes excitement, insomnia aggression in first few weeks Possibly increased suicidal ideation Lower seizure thresholds
Serotonin syndrome Caused by: S/S:
All SSRI can potentially cause this especially when used with MAOI Characterized by: tremor, hyperthermia, CV collapse—>death
Discontinuation syndrome Caused by S/S
Potentially caused by SSRI after their abrupt withdrawal ((Fluoxetine—>lowest risk due its longer T1/2 and active metabolite)) S/S: headache, malaise, flu like, agitation, irritability, nervousness, sleep difficulties
Venlafaxine, Duloxetine (SNRI) MOA
-Inhibit serotonin and noradrenaline reuptake -Little activity at a-adrenergic, muscuranic, histamine receptor—> less of the side effects resulting from these receeptors
Venlafaxine Pharmacokinetics
Minimal inhibition or CYP450 Substrate for CYP2D6
VENLAFAXINE Side effects
-Nausea -Headache -Sexual Dysfunction -Disziness -Insomnia -Sedation -Constipation High dose—> HTN, TACHYCARDIA
Duloxetine Metabolism
Highly metabolized in liver—> inactive metabolites !Avoid in pt with liver dysfunction
Duloxetine side effects
Gi (common); nausea, dry mouth, constipation Others: insomnia, dizziness, somnolence, sweating, sexual dysfunction. May increase bp and hr
Duloxetine drug-drug interaction
Moderate inhibitor of CYPD26–> increase conc of drugs (antipsychotics) metabolized by it
Tricyclic antidepressants
Imipramine
Imipramine MOA
TCA Therapeutic —>Inhibit serotonin and noradrenaline reuptake +block serotonergic, a adrenergic, histaminic, muscarinic receptors—> adverse effects?
Imipramine Therapeutic uses
Moderate-severe depression Some anxiety disorders eg anxiety attacks
Imipramine Pharmacokinetics
Well absorbed orally Metabolized by hepatic microsomal system—> sensitive to agents that induce/inhibit CYP450?
Imipramine Adverse effects
Antimuscarinic: blurred vision, dry mouth, urinary retention and constipation A adrenergic block: Orthostatic hypotension, dizziness, reflex tachy CV: arrhythmia and SD Sedation: in first few weeks of use Weight gain
Imipramine Precautions
If bipolar pt—> antidepressants may cause a switch to manic behavior Suicidal pt—> LIMITED QUANTITIES OF TCA cuz low TI there4 lethal imipramine dose is 5-6 maximal dose.
TCA Interaction with MAOI
Mutual enhancements—> htn, hyperpyrexia, convulsions, coma